Anxiety in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior

Behavioural Pharmacology

Volumn 10, Issue 5, 1999, Pages 435-443

  McGrath, M J ^a   Campbell, K M ^a   Veldman, M B ^a   Burton, Frank H ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Amygdala; Biting; Cholera toxin; Dopamine D1 receptor; Intercalated nucleus; Leaping; Perseverance; Transgenic mouse

Indexed keywords

CHOLERA TOXIN; DOPAMINE 1 RECEPTOR; YOHIMBINE;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT PERIOD; LIMBIC SYSTEM; LONG TERM POTENTIATION; MALE; MOUSE; NERVE STIMULATION; NONHUMAN; OBSESSION; OPEN FIELD TEST; TRANSGENIC MOUSE;

EID: 0032843204     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199909000-00001     Document Type: Article

References (44)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders (4th edn). Washington, DC: American Psychiatric Association.
2. Barbas H (1993). Organization of cortical afferent input to orbitofrontal areas in the rhesus monkey. Neuroscience 56:841-864.
3. Bergson C, Mrzlijak L, Smiley JF, Pappy M, Levenson R, Goldman-Rakic PS (1995). Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptor in primate brain. J Neurosci 15:7821-7836.
4. Blanchard RJ, Taukulis HK, Rodgers RJ, Magee LK, Blanchard CD (1993). Yohimbine potentiates active defense responses to threatening stimuli in Swiss-Webster mice. Pharmacol Biochem Behav 44:673-681.
5. Breiter HC, Rauch SL, Kwong KK et al. (1996). Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psych 53:595-606.
6. Bremner JD, Krystal JH, Southwick SM, Charney DS (1996). Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 23:28-38.
7. Broocks A, Briggs NC, Pigott TA et al. (1997). Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenlypiperazine (m-CPP) with and without ondanesetron pretreatment. Psychopharmacology 130:91-103.
8. Bruhwyler J, Chleide E, Liegeois JF, Delarge J, Mercier M (1990). Anxiolytic potential of sulpiride, clozapine and derivatives in the open-field test. Pharmacol Biochem Behav 36:57-61.
9. Bruhwyler J, Chleide E, Liegeois JF, Delarge J, Mercier M (1991). Effects of specific dopaminergic agonists and antagonists in the open-field test. Pharmacol Biochem Rehav 39:367-371.
10. Campbell KM, Rohland RM, McGrath MJ, Satoskar SD, Burton FH (1998). Detecting subtle differences in behavior using waveform display analysis. Physiol Behav 64:83-91.
11. Campbell KM, de Lecca L, Severynse DM et al. (1999a). OCD-like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons. J Neurosci 19:5044-5053.
12. Campbell KM, McGrath MJ, Burton FH (1999b). Behavioral effects of cocaine on a transgenic mouse model of corticallimbic compulsion. Brain Res 833:216-224.
13. Cath DC, Hoogduin CAL, van de Wetering BJM, van Woerkom TCAM., Roos RAC, Rooymans HGM (1992). Tourette syndrome and obsessive-compulsivie disorder. Adv Neurol 58:33-41.
14. Cole JC, Rodgers RJ (1993). An ethological analysis of the effects of chlodiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze. Behav Pharmacol 4:573-580.
15. Dawson GR, Tricklebank MD (1995). Use of the elevated plus maze in the search for novel anxiolytic agents. Trends Pharmacol Sci 16:33-37.
16. Delfs JM, Kelly AE (1990). The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience 39:59-67.
17. Ferry B, Magistretti PJ, Pralong E (1997). Noradrenaline modulates glutamate-mediated neurotransmission in the rat. basolateral amygdala in vitro. Eur J Neurosci 9:1356-1364.
18. Fray PJ, Sahakian BJ, Robbins TW, Koob GF, Iverson SD (1980). An observational method for quantifying the behavioral effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine. Psychopharmacology 69:253-259.
19. Gaspar P, Bloch B, LcMoine C (1995). D1 and D2 receptor gene expression in the rat frontal cortex: cellular localization in different classes of efferent neurons. Eur J Neurosci 7:1050-1063.
20. Gerfen CR, Wilson JW (1996) The basal ganglia. Handbook Chem Neuroanatomy 12:371-468.
21. Grobin AC, Deutch AY (1998). Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat. J Pharmacol Exp Ther 285: 350-357.
22. Hollander E, Fay M, Cohen B, Campeas R, Gorman JM, Liebowitz MR (1988). Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findings. Am J Psychol 145:1015-1017.
23. Huang Q, Zhou D, Chase K, Gusella JF, Aronia N, DiFiglia M (1992). Immunocytochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre-and postsynaptic localization, and prevalence in the basal ganglia, limbic system and thalamic reticular nucleus. Proc Natl Acad Sci USA 89:11988-11992.
24. Institute of Laboratory Animal Resources (1996). Guide for the Care and Use of Laboratory Animals/Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council (7th edn). Washington, DC: National Academy Press.
25. Jacobson R (1986), Disorders of facial recognition, social behavior, and affect after combined bilateral amygdalotomy and sucaudate tractotomy - a clinical and experimental study. Psychol Med 16:439-450.
26. Johnston AL, File SE (1989). Yohimbine's anxiogenic action: evidence for noradrenergic and dopamincrgic sites. Pharmacol Biochem Behav 32:151-156.
27. Kaneko T, Caria MA, Asanuma H (1994). Information processing within the motor cortex. II. Intracortical connections between neurons receiving somatosensory cortical input and motor output neurons of the cortex. J Comp Neurol 345:172-184.
28. Kurlan R, Kersun J, Ballantine HT, Caine ED (1980). Neurosurgical treatment of severe obsessive-compulsive disorder associated with Tourette's syndrome. Mov Disord 5:152-155.
29. Lilly R, Cummings JL, Benson DF, Frankel M (1983). The human Kluver-Bucy syndrome. Neurology 33:1141-1145.
30. Lister RG (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185.
31. McDonald AJ (1987). Organization of amygdaloid projections to the mediodorsal thalamus and prefrontal cortex: a fluorescent retrograde transport study in the rat. J Comp Neurol 261:46-58.
32. McDonald AJ, Augustine JR (1993). Localization of GABA-like immunoreactivity in the monkey amygdala. Neuroscience 52:281-294.
33. McGrath MJ, Campbell KM, Burton FH. (1999). The role of cognitive and affective processing in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior, Behav Neurosci (in press).
34. Morecraft RJ, Geula C, Mesulam MM (1992), Cytoarchitecture and neural afferents of orbitofrontal cortex in the brain of the monkey. J Comp Neurol 323:341-358.
35. Pellow S, Chopin P, File SE, Briley M (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14:149-167.
36. Rapoport JL, Swedo SE, Leonard HL (1992). Childhood obsessive compulsive disorder. J Clin Psychol 53:11-16.
37. Rosen JB, Davis M (1988). Enhancement of acoustic startle by electrical stimulation of the amygdala. Behav Neurosci 102:195-202, 324.
38. Scibilia RJ, Lachowicz JE, Kilts CD (1992). Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain. Synapse 11:146-154.
39. Simon P, Panissaud C, Costentin J (1992). Sulpiride anxiogenic-like effect inhibition by a D1 dopamine receptor antagonist. NeuroReport 3:941-942.
40. Simon P, Panissaud C, Costentin J (1993). Anxiogenic effects induced by stimulation of dopamine receptors. Pharmacol Biochem Behav 45:685-690.
41. Simon P, Panissaud C, Costentin J (1994). The stimulant effect of modafinil on wakefulncss is not associated with an increase in anxiety in mice. Psychopharmacology 114:597-600.
42. Stoetter B, Braun AR, Randolph C et al. (1992). Functional neuroanatomy of Tourette syndrome: limbic-motor interactions studied with FDG PET. Adv Neurol 58:213-226.
43. Yamamoto T, Samejima A, Oka H (1990). The mode of synaptic activation of pyramidal neurons in the cat primary somatosensory cortex: an intracellular HRP study. Exp Brain Res 80:12-22.
44. Zhang X, Gelowitz DL, Lai CT, Boulton AA, Yu PH (1997). Gradation of kainic acid-induced rat limbic seizures and expression of hippocampal heat shock protein-70. Eur J Neurosci 9:760-769.